Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Arcadia Biosciences reports positive Q1 results, eyes revenue growth

Arcadia Biosciences delivered strong financial performance in Q1 2024, driven by revenue growth and cost management. The company faces challenges in retail execution but has opportunities for revenue growth through brand expansions and strategic partnerships.

Arcadia Biosciences reports strong Q2 driven by Zola growth

Arcadia Biosciences delivered solid financial performance in Q2 2024 driven by Zola Coconut Water.
Efficient cost-saving measures and strategic asset monetization bolstered profitability.
Challenges include managing increased costs and sustaining growth momentum.
Opportunities lie in expanding Zola brand, diversifying revenue streams, and strategic partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

DAVIS, Calif.--(BUSINESS WIRE)--Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its 2022 fourth-quarter and full-year financial and business results after market close on March 30, 2023. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss fourth-quarter and year-end results and the year's key strategic achievements.

Arcadia Biosciences (RKDA) Announces Date of Fourth-Quarter and Full-Year 2022 Financial Results and Business Highlights Conference Call

DAVIS, Calif. , March 2, 2023 /PRNewswire/ --  Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements for the purchase and sale of 666,334 shares of its common stock (or common stock equivalents), Series A preferred investment options to purchase up to an aggregate of 666,334 shares of common stock and Series B preferred investment options to purchase up to an aggregate of 666,334 shares of common stock at a purchase price of $9.00 per share of common stock (or common stock equivalent) and associated preferred investment options in a private placement priced at a premium to market under Nasdaq rules.

Arcadia Biosciences (RKDA) Announces $6.0 Million Private Placement Priced at a Premium to Market Under Nasdaq Rules

Local Bounti Corp

The Real Good Food Co

Smart for Life Inc

The most oversold stocks in the consumer staples sector presents an opportunity to buy into undervalued companies.

4 Cheapest Defensive Stocks You Should Think About

-- Single ingredient pasta provides four times the fiber of traditional pasta with no sacrifice on taste -- DAVIS, Calif. , Jan. 18, 2023 /PRNewswire/ -- GoodWheat™ pasta is breaking new ground in helping consumers make healthier food choices by receiving the American Heart Association's Heart-Check mark on all five varieties of its single ingredient noodles.

GoodWheat™ Pasta Receives American Heart Association® Heart-Check Certification

Bunge Global SA

Cal-Maine Foods

With the Agriculture - Products industry set to gain from solid demand, stocks like Bunge Limited (BG), CalMaine Foods (CALM) and Arcadia Biosciences (RKDA) are poised to ride on this positive trend.

3 Stocks Worth a Look in the Thriving Agriculture - Products Industry

Better-for-you pasta brand is now available in more than 1,000 stores within six months of launch DAVIS, Calif. , Dec. 8, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced its GoodWheat™ pasta is now available in more than 1,000 retail locations coast-to-coast, doubling distribution in the six months since launch and providing consumers with a better-for-you version of a household staple.

Arcadia Biosciences (RKDA) Doubles Retail Footprint for GoodWheat™ Pasta

-- Pam Haley to be replaced by Thomas J. Schaefer effective January 3, 2023 -- DAVIS, Calif.

Arcadia Biosciences (RKDA) Announces CFO Transition

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Arcadia Biosciences (RKDA) Reports Q3 Loss, Lags Revenue Estimates

Arcadia Biosciences Inc (NASDAQ:RKDA ) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Stan Jacot - President and Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Dipesh Patel - H.C. Wainwright Operator Good afternoon, and welcome to the Arcadia Biosciences Third Quarter 2022 Earnings Conference Call.

Arcadia Biosciences Inc (RKDA) Q3 2022 Earnings Call Transcript

-- GoodWheat™ Pasta distribution doubles from Q2 ---- Gross margins improve to 28% ---- Streamlined operations focus on higher-margin brands --  DAVIS, Calif., Nov. 10, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces Strong Third Quarter 2022 Financial Results and Business Highlights

DAVIS, Calif. , Oct. 27, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the third quarter and first nine months of 2022 after market close on November 10, 2022.

Arcadia Biosciences (RKDA) Announces Date of Third Quarter 2022 Financial Results and Business Highlights Conference Call

DAVIS, Calif. , Aug. 16, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced the closing of its previously announced registered direct offering of 4,722,506 shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.05876 per share, priced at-the-market under Nasdaq rules.

Arcadia Biosciences (RKDA) Announces Closing of $5.0 Million Registered Direct Offering Priced At-the-Market

DAVIS, Calif. , Aug. 12, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc. ® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, announced today that it has entered into securities purchase agreements with a single healthcare-focused institutional investor for the purchase and sale of 4,722,506 shares of its common stock (or common stock equivalents) at a purchase price of $1.05876 per share in a registered direct offering priced at-the-market under Nasdaq rules.

Arcadia Biosciences (RKDA) Announces $5.0 Million Registered Direct Offering Priced At-The-Market

Arcadia Biosciences Inc (NASDAQ:RKDA ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Stan Jacot - President and Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Ben Klieve - Lake Street Capital Markets Brian Wright - ROTH Capital Partners Operator Good afternoon, and welcome to the Arcadia Biosciences Second Quarter 2022 Earnings Conference Call. Today's presenters will be Stan Jacot, President and Executive Officer; and Pam Haley, Chief Financial Officer of Arcadia.

Arcadia Biosciences Inc (RKDA) CEO Stan Jacot on Q2 2022 Results - Earnings Call Transcript

– Revenue increased 175% from Q2 2021 – – GoodWheat™  pasta  successfully launched in retail and online – – $2M milestone achievement recognized for HB4® soybean approval in China – DAVIS, Calif., Aug. 11, 2022 /PRNewswire/ --  Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces Strong Second-Quarter and First-Half 2022 Financial Results and Business Highlights

DAVIS, Calif. , July 28, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the second quarter and first half of 2022 after market close on August 11, 2022.

Arcadia Biosciences (RKDA) Announces Date of Second Quarter 2022 Financial Results and Business Highlights Conference Call

Agriforce Growing Systems Ltd

Applied UV

Ricebran Technologies

Penny stocks to watch under $3 The post Best Penny Stocks To Buy? 4 Under $3 To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Best Penny Stocks To Buy? 4 Under $3 To Watch Now

Sixteen years in the making, GoodWheat™ pasta redefines the pasta category with one simple ingredient as consumers seek to amp up nutrition without sacrificing taste DAVIS, Calif. , June 1, 2022 /PRNewswire/ -- Pasta-lovers seeking to add fiber to their diets without sacrificing taste will soon be boiling over with joy with today's debut of GoodWheat™ pasta, a superior, single-ingredient noodle that delivers better nutrition and unmatched taste.

NEW GOODWHEAT™ PASTA SERVES UP PASTA REVOLUTION WITH FORKFUL OF FIBER THAT NEVER TASTED SO GOOD

Clever Leaves Holdings Inc

iQIYI

Why these penny stocks climbed during trading today The post 3 Penny Stocks That Climbed Today, Here's Why  appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks That Climbed Today, Here's Why

Arcadia Biosciences, Inc. (NASDAQ:RKDA ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Stan Jacot - President and Chief Executive Officer Pam Haley - Chief Financial Officer Conference Call Participants Benjamin Klieve - Lake Street Capital Markets Operator Good afternoon. And welcome to Arcadia Biosciences First Quarter 2022 Earnings Conference Call.

Arcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q1 2022 Results - Earnings Call Transcript

Bioceres Crop Solutions Corp

–  Sales increased 48% from Q4 2021 – – First retail orders of GoodWheat™  pasta shipped – – HB4® soybeans approved in China, $2M milestone anticipated – DAVIS, Calif. , May 12, 2022 /PRNewswire/ --  Arcadia Biosciences, Inc.

Arcadia Biosciences (RKDA) Announces First Quarter 2022 Financial Results

DAVIS, Calif. , May 5, 2022 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today announced that it will release its financial and business results for the first quarter of 2022 after market close on May 12, 2022.

Arcadia Biosciences Announces Date of First Quarter 2022 Financial Results and Business Highlights Conference Call

Arcadia Biosciences, Inc. (RKDA) CEO Stan Jacot on Q4 2021 Results - Earnings Call Transcript

Arcadia Biosciences Inc (NASDAQ: RKDA) reported fourth-quarter revenue declined 70% year-over-year to $2.17 million, missing the consensus of $3.33 million. Net loss was $(9.3) million of $(0.42) per share, compared to the $8.9 million of income recognized in 4Q20, missing the consensus.

Arcadia Biosciences Shares Plunge Afterhours As Q4 Earnings Miss Estimates

– Strong balance sheet entering 2022 – – Expanded consumer product offerings in on-trend categories – – Experienced CPG talent added throughout organization – DAVIS, Calif. , March 30, 2022 /PRNewswire/ --  Arcadia Biosciences, Inc.

News for Arcadia Biosciences Stock (RKDA)